F18-MHF: Orthopedic Implants-Associated Infection Detection

RecruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

November 4, 2024

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Knee DiseaseKnee Infection
Interventions
DRUG

[F-18]MHF

Following intravenous injection of 10 ± 2 mCi (370 ± 74 MBq) \[F-18\]MHF as a bolus, dynamic PET imaging of the lower limbs will be acquired for approximately 90 minutes. The acquired images will be processed. The uptake pattern of \[F-18\]MHF around infected orthopedic knee implant will be determined and compared with its uptake pattern around non-infected knee implants.

Trial Locations (1)

30322

RECRUITING

Emory University Hospital, Atlanta

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Emory University

OTHER